National Research Corp Stock Cash Flow From Operations
| NRC Stock | USD 15.10 0.41 2.79% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess National Research's long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. National Research Corp Company Cash Flow From Operations Analysis
National Research's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current National Research Cash Flow From Operations | 34.62 M |
Most of National Research's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Research Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, National Research Corp has 34.62 M in Cash Flow From Operations. This is 93.43% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The cash flow from operations for all United States stocks is 96.43% higher than that of the company.
National Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Research's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Research could also be used in its relative valuation, which is a method of valuing National Research by comparing valuation metrics of similar companies.National Research is currently under evaluation in cash flow from operations category among its peers.
National Fundamentals
| Return On Equity | 0.58 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 424.55 M | ||||
| Shares Outstanding | 23.1 M | ||||
| Shares Owned By Insiders | 46.33 % | ||||
| Shares Owned By Institutions | 50.85 % | ||||
| Number Of Shares Shorted | 406.16 K | ||||
| Price To Earning | 26.72 X | ||||
| Price To Book | 16.36 X | ||||
| Price To Sales | 2.49 X | ||||
| Revenue | 143.06 M | ||||
| Gross Profit | 84.63 M | ||||
| EBITDA | 41.31 M | ||||
| Net Income | 24.78 M | ||||
| Cash And Equivalents | 32.97 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 62.68 M | ||||
| Debt To Equity | 0.37 % | ||||
| Current Ratio | 1.31 X | ||||
| Book Value Per Share | 0.92 X | ||||
| Cash Flow From Operations | 34.62 M | ||||
| Short Ratio | 3.90 X | ||||
| Earnings Per Share | 0.77 X | ||||
| Price To Earnings To Growth | 3.42 X | ||||
| Number Of Employees | 368 | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 348.87 M | ||||
| Total Asset | 132.54 M | ||||
| Retained Earnings | (17.06 M) | ||||
| Working Capital | (16.26 M) | ||||
| Current Asset | 27.6 M | ||||
| Current Liabilities | 12.83 M | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 1.24 % | ||||
| Net Asset | 132.54 M | ||||
| Last Dividend Paid | 0.48 |
About National Research Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Research Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Research using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Research Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:Check out National Research Piotroski F Score and National Research Altman Z Score analysis. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Business Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.